J.D. Mowery, Bora, says tariffs localize biopharma supply chains, the "biotech freeze" mandates robust data, and AI rapidly ...

Maggie Saykali, Cefic, explains that Western pharma vulnerability stems from market loss to Asia, caused largely by ...

Mebarki (SGD Pharma): One of our very important innovations is Sealian, which is a unique internal treatment that confers additional functionality to the vial, and for which we have a strong ...

The discussion turned to vital role of the human element despite AI’s increasing integration into recruitment. Recruiting leaders use AI to reduce administrative tasks, thereby giving them free time ...

Regulatory scrutiny on traditional excipients like titanium dioxide and talc poses significant challenges, necessitating robust scientific evidence to address concerns. Sustainable practices in ...

AI’s true power lies in pattern recognition across messy, real-world data: Natural language processing extracts phenotypes, comorbidities, and device usability feedback from unstructured clinical ...

CPHI Pharma Awards 2025 recognized innovations in bio/pharmaceutical development, emphasizing sustainability, drug delivery, ...

As Thermo Fisher’s Jennifer Cannon explains in this first part of a two-part interview, the collaboration is intended to help ...

AI and accelerated computing are transforming the bio/pharmaceutical sector by addressing organizational, technological, and ...

Nigel Langley of gChem stresses excipient innovation, safer solvents, and supply chain resilience for pharma’s future in part ...

In this part 2 of a 2-part interview regarding the presentation “Beyond Traditional Markets: The Strategic Importance of ...

Nigel Langley of gChem discusses the company’s DMSO, proactive pharma strategies, and more in part 1 of a 2-part interview ...